
IBM Stock: Stable Dividend or Stagnant Investment?
The AI race has heated up significantly but returns on…
Trailing 12 Months | Fiscal Quarters | |||||
---|---|---|---|---|---|---|
Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
Income Statement | ||||||
Revenue | $4.4B | $4.7B | $5.4B | $1.3B | $1.4B | |
Gross Profit | $2B | $2B | $2.3B | $560M | $610.3M | |
Operating Income | $677.6M | $873.9M | $927.6M | $226.5M | $247.5M | |
EBITDA | $832.7M | $1.9B | $1.4B | $369.2M | $373.8M | |
Diluted EPS | -$0.29 | $5.71 | $4.71 | $1.42 | $1.75 |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Balance Sheet | ||||||
Current Assets | $1.2B | $1.9B | $2B | $2.2B | $1.9B | |
Total Assets | $6.6B | $11.7B | $10.8B | $11.4B | $10B | |
Current Liabilities | $505.9M | $904.3M | $796.5M | $913.7M | $891.1M | |
Total Liabilities | $2.7B | $5.1B | $4.8B | $5B | $3.6B | |
Total Equity | $3.9B | $6.6B | $6B | $6.4B | $6.4B | |
Total Debt | $1.7B | $3.3B | $3.1B | $3.3B | $2.2B |
Trailing 12 Months | Fiscal Quarters | |||||
---|---|---|---|---|---|---|
Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
Cash Flow Statement | ||||||
Cash Flow Operations | $712.9M | $934.3M | $1.1B | $291.2M | $332.8M | |
Cash From Investing | -$212.2M | -$869.3M | $363M | -$118.9M | -$123.9M | |
Cash From Financing | -$581.4M | -$133.4M | -$1.5B | -$198M | -$214.4M | |
Free Cash Flow | $349.3M | $594M | $751.4M | $172.3M | $243.6M |
Steris is an Ireland-domiciled medical technology company focused on sterilization services and infection prevention. The company is the global leader in contract sterilization services, ensuring the safe delivery of single-use and implantable medical equipment to hospitals around the world. Additionally, Steris sells sterilizers, washer-disinfectors, and other decontamination equipment and supplies for use by care provider facilities and in biopharma manufacturing sites. Domiciled in the United States before its inversion to Ireland, the firm derives approximately 70% of its revenue from Healthcare Services, 19% from Applied Sterilization Technologies, or AST, and 11% from life sciences services after the divestment of its dental products business.
In the current month, STE has received 2 Buy ratings 4 Hold ratings, and 0 Sell ratings. The STE average analyst price target in the past 3 months is $250.13.
According to analysts, the consensus estimate is that Steris PLC share price will rise to $250.13 per share over the next 12 months.
Analysts are divided on their view about Steris PLC share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Steris PLC is a Sell and believe this share price will drop from its current level to $230.00.
The price target for Steris PLC over the next 1-year time period is forecast to be $250.13 according to 6 Wall Street analysts, 2 of them rate the stock a Buy, 0 rate the stock a Sell, and 4 analysts rate the stock a Hold.
According to Wall Street analysts, the consensus rating for Steris PLC is a Hold. 4 of 6 analysts rate the stock a Hold at this time.
You can purchase shares of Steris PLC via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Steris PLC shares.
Steris PLC was last trading at $231.49 per share. This represents the most recent stock quote for Steris PLC. Yesterday, Steris PLC closed at $232.74 per share.
In order to purchase Steris PLC stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Signup to receive the latest stock alerts
The AI race has heated up significantly but returns on…
Trimble (NASDAQ:TRMB) is a hardware and software tech company that…
It seems like right now is a good time to…
Market Cap: $3.6T
P/E Ratio: 39x
Market Cap: $2.8T
P/E Ratio: 32x
Market Cap: $2.6T
P/E Ratio: 36x
Willdan Group [WLDN] is down 3.66% over the past day.
Pro-Dex [PDEX] is up 10.33% over the past day.
Samsara [IOT] is down 3.68% over the past day.